Jun 8, 2023, 10:21 AM by

Jun 8, 2023, 10:21 AM by

The global cancer biological therapy industry size was exhibited at USD 98.85 billion in 2022 and is projected to hit around USD 214 billion by 2032, growing at a CAGR of 8.03% during the forecast period 2023 to 2032.

Jun 8, 2023, 10:20 AM by

Jun 8, 2023, 10:20 AM by

Jun 8, 2023, 10:20 AM by

Jun 8, 2023, 10:20 AM by

The first initiative of its kind using spatial omics technology, MOSAIC holds the potential to open a new field in oncology treatment research. Collaborating with Gustave Roussy, the University of Pittsburgh through the UPMC Hillman Cancer Center, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander- Universität Erlangen-Nürnberg, Charité - Universitätsmedizin Berlin, NanoString Technologies and other providers of analytical instrumentation and assays for spatial biology, Owkin will invest $50 million to build MOSAIC. It will use 7,000 tumor samples from patients, making it over 100 times larger than any existing spatial omics datasets. Owkin and the MOSAIC partners will mine this resource for immune-oncology disease subtypes in pursuit of biomarkers and novel therapies.

Jun 8, 2023, 01:00 AM by User Not Found

Bio-IT World | An international team of researchers has completed preliminary testing of a swallowable device for collecting samples from people under standard, day-to-day conditions to better understand what is happening inside their small intestine. The lengthy organ has up to how been inaccessible unless individuals first fasted and were sedated.

Jun 7, 2023, 01:00 AM by User Not Found

Bio-IT World | Bioengineers at the University of Michigan (U-M) have seriously scaled up data collection on bacterial species known to affect human health with robots and an artificial intelligence (AI) system that learns from scratch without the need for big databases of knowledge to train on. Dubbed BacterAI, the platform generates its own data and quickly gets smarter by playing a game doling out reward points for accurately predicting the outcome of an experiment.

Jun 6, 2023, 01:00 AM by User Not Found

Bio-IT World | Researchers at the University of Illinois Urbana-Champaign believe they have come up with an attractive approach to the battle against bacteria that can infect orthopedic implants—as well as the surfaces people encounter in everyday life, smartphone screens and kitchen countertops. The smart surgical implant coating contains no chemicals but was instead inspired by the wings of cicadas and dragonflies that are naturally antibacterial through physical interactions.

Jun 5, 2023, 16:19 PM by

Jun 5, 2023, 15:52 PM by

VERICHEM LABORATORIES now offers all customers free access to the company’s web-based and online calibration verification data reduction and test reporting programs.

Jun 5, 2023, 15:51 PM by

Growing demand for personalized medicine, technological innovations in medical technology both for diagnosis and treatment of patients, increasing cases of drug reactions and side effects, and rising demand for next-generation sequencing are some of the leading factors driving the growth of companion diagnostics market.

Jun 5, 2023, 15:37 PM by

The cutting-edge software integration enables researchers to design oligo assembly reactions, automate the reaction setup, order the needed DNA, and integrate with lab automation, all within a single platform

Jun 5, 2023, 15:36 PM by

Strategic board members from the digital therapeutics and behavioral cough space join Hyfe AI as they prepare for their next step as an end-to-end cough company.

Jun 5, 2023, 15:36 PM by

The DNAnexus core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics data.

Jun 5, 2023, 15:33 PM by

Jun 5, 2023, 15:33 PM by

Orthonika Limited, a spin-out from Imperial College London, has been awarded a £1.34 million grant from Innovate UK, the UK’s innovation agency, to complete pre-clinical development and testing of its synthetic total meniscus replacement in preparation for the clinic.

Jun 5, 2023, 15:31 PM by

Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham Hughes, M.D.; and David Miller, Ph.D. – will help guide Almaden as it enables companies and labs to accelerate genomic discovery and drug development via its streamlined data analysis platform, g.nome™.

Jun 5, 2023, 15:30 PM by

Jun 5, 2023, 15:30 PM by

Leading Japanese biopharma company expands enterprise-level deployment of Genedata Bioprocess to automate workflows and increase operational efficiency within and between their R&D sites